Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.
Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama.
Cancer. 2021 Jul 15;127(14):2571-2578. doi: 10.1002/cncr.33546. Epub 2021 Mar 30.
The quality of adult end-of-life (EOL) cancer care has benefited from quality measures, but corresponding pediatric measures are lacking. Therefore, the authors used a validated expert panel method to recommend EOL quality measures for pediatric oncology.
The authors used the modified Delphi method to assess potential quality measures. Panelists were selected on the basis of professional organization nominations and expert qualifications. Pediatric and adult oncology, pediatric palliative care, social work, nursing, and hospice were represented. The authors provided the panel with a literature review on 20 proposed measures derived from adult measures and bereaved family interviews. The panel first scored the importance of each measure on a 9-point scale and then discussed the measures via a conference call. The panel then rescored the measures. According to a priori standards, measures with median scores ≥ 7 with at least 7 of 9 experts ranking it as ≥4 were endorsed.
The 16 endorsed measures included measures related to avoidance of medically intense care (eg, intensive care unit death and intubation in the last 14 days of life), death location (eg, death in the preferred location), hospital policies/programs (eg, the removal of visitor restrictions at EOL and the presence of a bereavement program), and supportive care services (eg, pediatric palliative care involvement and sibling needs assessment). Unendorsed measures included avoidance of chemotherapy at EOL and home death.
Expert panel-endorsed quality measures have been developed for EOL care in pediatric oncology. The measures need validation with bereaved families and further refinement before they are ready for real-world application as a tool for standardizing EOL care in pediatric oncology.
Quality measures for end-of-life care for children with cancer lag behind adult quality measures. Therefore, the authors have conducted an expert panel to develop an endorsed list of quality measures for end-of-life care for children with cancer. The 16 endorsed measures include measures related to avoidance of medically intense care (eg, intensive care unit death and intubation in the last 14 days of life), location of death (eg, death in the preferred location), hospital policies/programs (eg, the removal of visitor restrictions at the end of life and the presence of a bereavement program), and supportive care services (eg, pediatric palliative care involvement and sibling needs assessment).
成人临终(EOL)癌症护理质量受益于质量措施,但相应的儿科措施却缺乏。因此,作者使用经过验证的专家小组方法为儿科肿瘤学推荐 EOL 质量措施。
作者使用改良 Delphi 方法评估潜在的质量措施。小组成员是根据专业组织提名和专家资格选定的。包括儿科和成人肿瘤学、儿科姑息治疗、社会工作、护理和临终关怀。作者向小组提供了一份关于从成人措施和失去亲人的家庭访谈中得出的 20 项拟议措施的文献综述。小组首先对每项措施的重要性进行 9 分制评分,然后通过电话会议讨论这些措施。然后,小组重新对这些措施进行评分。根据事先设定的标准,中位数得分≥7,且至少有 9 位专家中≥4 位专家将其评为≥4 的措施被认可。
16 项被认可的措施包括与避免医疗密集护理相关的措施(例如,重症监护病房死亡和生命最后 14 天插管)、死亡地点(例如,在首选地点死亡)、医院政策/计划(例如,临终时取消访客限制和存在丧亲计划)和支持性护理服务(例如,儿科姑息治疗参与和兄弟姐妹需求评估)。未被认可的措施包括临终时避免化疗和在家中死亡。
专家小组认可的 EOL 护理质量措施已在儿科肿瘤学中制定。这些措施需要经过失去亲人的家庭验证,并进一步完善,然后才能作为标准化儿科肿瘤学 EOL 护理的工具在现实世界中应用。
儿童癌症的临终关怀质量措施落后于成人质量措施。因此,作者进行了一个专家小组,为儿童癌症的临终关怀制定了一份认可的质量措施清单。16 项被认可的措施包括与避免医疗密集护理(例如,生命最后 14 天的重症监护病房死亡和插管)、死亡地点(例如,在首选地点死亡)、医院政策/计划(例如,临终时取消访客限制和存在丧亲计划)和支持性护理服务(例如,儿科姑息治疗参与和兄弟姐妹需求评估)相关的措施。